GUADALAJARA, Mexico — The US Food and Drug Administration (FDA) defines statin intolerance as "the inability to tolerate at least two statins at the lowest approved doses due to musculoskeletal ...

(Medical Xpress) -- Millions of people take statins, the blockbuster drug that lowers low-density lipoprotein (LDL), the so-called bad cholesterol. But as many as 20 percent of them develop adverse ...

Please provide your email address to receive an email when new articles are posted on . The true incidence of statin intolerance is estimated to be between 5% and 10%. For most patients, clinicians ...

On the first day here in New Orleans at the 2023 American College of Cardiology (ACC) meeting, we learned the details of the placebo-controlled CLEAR Outcomes trial of bempedoic acid in ...

Please provide your email address to receive an email when new articles are posted on . The National Lipid Association updated its scientific statement on statin intolerance with a revised definition ...

NEW ORLEANS -- Bempedoic acid (Nexletol) provided compelling clinical benefit in terms of primary and secondary cardiovascular prevention for statin-intolerant patients who need cholesterol lowering, ...

Scientists have discovered how atorvastatin, a commonly prescribed cholesterol medication, can interfere with a protein that regulates calcium in muscle cells. The findings offer new clues about ...

Bempedoic acid is associated with a reduction in major adverse cardiovascular events among statin-intolerant primary prevention patients, according to a study published online June 24 in the Journal ...

A recent simulation study published in the journal Scientific Reports analyzed representative data of over two million outpatients in Germany, in which the researchers reported that a combination of ...

Have you heard of the most prescribed medicines for high cholesterol, diabetes, and heart disease? They're called statins. If you have a history of high cholesterol, chances are your doctor has ...

Those who took bempedoic acid once a day had on average a 30.2 mg/dL or 21.3% reduction in low-density lipoprotein (LDL) cholesterol levels over about a three-year period. Elevated LDL levels can lead ...